Description
This book explores the growing significance of marine organisms as a source of novel bioactive compounds for pharmaceuticals, nutraceuticals, and agricultural applications. It delves into the history of drug discovery from marine sources, with a focus on marine metabolites found in sponges, fish, mollusks, seaweeds, and microorganisms. The book highlights the potential of these compounds in disease treatment, antibiotic development, and commercial utilization. It also addresses the challenges of sustainable production through fermentation and aquaculture. Drawing on recent advances in metabolic engineering and genomics, this work offers insights into the promising future of marine-derived drugs.